The following may be placed on the market following notification to the Agency:
complementary medicines without indications, the active substances of which are included in lists for specific therapy approaches;
other medicinal products or groups of medicinal products for which, due to their low risk potential, a simplified marketing authorisation proves to be disproportionate.
The Agency shall draw up the lists referred to in paragraph 1 letter a. It shall determine the medicinal products or groups of medicinal products referred to in paragraph 1 letter b and regulate the notification procedure.
0 commentaries
No commentaries are available for this article yet.